Patients Stopping Weight-Loss Jabs Regain Weight Four Times Faster Compared to People Using Diet and Exercise

A recent study suggests that patients who discontinue blockbuster GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight far faster than those who halt conventional diet and exercise regimens.

Findings released in a prominent health publication demonstrates that while overweight individuals frequently drop a large proportion of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month after stopping.

"Individuals purchasing these medications must be cognizant of the danger of quick rebound weight gain when the medication concludes," stated researcher Dr. Susan Jebb.

Such speed of regain suggests a return to pre-treatment mass within about 18 months.

Weighing Treatments

The analysis, which examined dozens of trials involving over 9,000 of participants, compared the outcomes of GLP-1 agonists with older methods.

Researchers emphasize that people who shed pounds through dieting typically experience a slower creep back—perhaps 100 grams monthly—after stopping.

Understanding the Fast Regain

Doctors propose the way of the drugs explains the amplified weight return.

GLP-1 drugs copy a natural hormone called GLP-1, which controls hunger.

"Long-term administration of the hormone levels far above than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication means appetite is uncontrolled, making overeating far more likely."

A Chronic Issue?

Medical guidelines advise the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

A number of clinicians argue that, given the likelihood of weight regain, the treatment should be considered life-long.

This opinion is supported by drug manufacturers, who say that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like diabetes.

User Accounts

Users who have stopped the medication report a intense return of cravings.

"It felt as if a switch flipping and you're instantly ravenous," recalled a patient.

This challenge is compounded if users have not developed sustainable lifestyle or habit changes during therapy.

Growing Interest

Recent estimates indicate that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.

• Adoption is more common among women than men.
• The 40s and 50s age group shows the greatest usage rates.
• A large proportion access the drugs through private healthcare rather than public health services.

Ultimately, experts caution that while the jabs are potent agents for shedding pounds, they are not a standalone cure and maintained weight loss hinges on combined behavioural management.